Mrs. Misty Milam Kennedy, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Military Rd, Marion, AR 72364 Phone: 870-739-5111 |
Rebecca Dale Northcutt Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Manor St, Marion, AR 72364 Phone: 870-739-5100 |
Wendy Michelle Lovan-bowers, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 606 Koser Dr, Marion, AR 72364 Phone: 870-739-4932 |
Mrs. Alissa Kathryn Gray, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 Manor St, Marion, AR 72364 Phone: 870-739-1600 Fax: 870-739-1605 |
Mk Therapy Co Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 149 Henry St, Marion, AR 72364 Phone: 870-278-4332 |
Kennedy Therapy Services Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 524 Evelyn Rd, Marion, AR 72364 Phone: 870-739-0040 |
Neat Rehab, Plc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 722 L H Polk Dr, Marion, AR 72364 Phone: 901-598-7078 |
Mrs. Girlie Nunez Candela, OTR/ L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1154 L H Polk St, Marion, AR 72364 Phone: 856-558-3265 |
News Archive
American Airlines and its parent company are suing to stop providing health care and life insurance benefits to current retirees. AMR Corp. and American filed the lawsuit Friday as part of their bankruptcy case in federal court in New York.
In the past two years, the Women's Health Initiative (WHI) trials of Premarin-based hormone therapy came to early ends because the risks outweighed the benefits.
In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off "switch" that paralyzes animals when exposed to a beam of ultraviolet light. The animals stay paralyzed even when the light is turned off. When exposed to ordinary light, the animals become unparalyzed and wake up.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).
› Verified 7 days ago